Demand Steady for LS Tools in US Academic Market, Investment Bank Says | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Demand by academic institutions in the US for life science tools has not weakened, with spending for such instruments increasing 13 percent year-over-year during the last three months of 2010, according to a survey conducted by investment firm Leerink Swann.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.